REDWOOD CITY, Calif. (AP) _ Coherus BioSciences Inc. (CHRS) on Monday reported a third-quarter loss of $38.5 million, after reporting a profit in the same period a year earlier.

The Redwood City, California-based company said it had a loss of 49 cents per share.

The drug developer posted revenue of $82.5 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News